Myocarditis Surveillance with High-Sensitivity Troponin I During Cancer Treatment with Immune Checkpoint Inhibitors

Sarah Waliany; Joel W Neal; Sunil Reddy; Heather Wakelee; Sumit A Shah; Sandy Srinivas; Sukhmani K Padda; Alice C Fan; A Dimitrios Colevas; Sean M Wu; Ronald M Witteles; Han Zhu

doi:10.1016/j.jaccao.2021.01.004

Myocarditis Surveillance with High-Sensitivity Troponin I During Cancer Treatment with Immune Checkpoint Inhibitors

JACC CardioOncol. 2021 Mar;3(1):137-139. doi: 10.1016/j.jaccao.2021.01.004. Epub 2021 Mar 16.

Authors

Sarah Waliany¹, Joel W Neal^{1

2

3}, Sunil Reddy^{1

2

3}, Heather Wakelee^{1

2

3}, Sumit A Shah^{1

2

3}, Sandy Srinivas^{1

2

3}, Sukhmani K Padda^{1

2

3}, Alice C Fan^{1

2

3}, A Dimitrios Colevas^{1

2

3}, Sean M Wu^{1

4

5}, Ronald M Witteles^{1

4}, Han Zhu^{1

4

5}

Affiliations

¹ Department of Medicine, Stanford University School of Medicine.
² Division of Oncology, Stanford University School of Medicine.
³ Stanford Cancer Institute.
⁴ Division of Cardiovascular Medicine, Stanford University School of Medicine.
⁵ Stanford Cardiovascular Institute, Stanford University School of Medicine.

No abstract available

Keywords: Immune checkpoint inhibitors; biomarker; cardiotoxicity surveillance; myocarditis; troponin I.

Grants and funding